AstraZeneca
AZN
#45
Rank
C$408.02 B
Marketcap
C$263.19
Share price
-1.67%
Change (1 day)
19.58%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): C$7.49

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$7.25. In 2024 the company made an earnings per share (EPS) of C$6.15 an increase over its 2023 EPS that were of C$5.20.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$7.4921.77%
2024C$6.1518.23%
2023C$5.2081.13%
2022C$2.87631.03%
2021C$0.39-88.11%
2020C$3.31136.89%
2019C$1.40-39.41%
2018C$2.30-28.27%
2017C$3.21-14.37%
2016C$3.7524.11%
2015C$3.02127.55%
2014C$1.33-51.96%
2013C$2.76-58.95%
2012C$6.73-32.2%
2011C$9.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.09 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.97 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.84-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.08-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.19 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.80-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$14.89 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.90 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.02-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.11-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK